Clinical Trial Update: Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SHP640 to povidone-iodine and placebo for adenoviral conjunctivitis was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Conjunctivitis

Drugs mentioned

• Povidone-iodine (povidone-iodine)
• SHP640 (SHP640)

Snippet

Sponsor: Shire | Conditions: Adenoviral Conjunctivitis | Phase 3 | Status: TERMINATED | Results posted: 2020-05-27